2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Highlights on HER2+ mCRC: Is Promising Trastuzumab Deruxtecan Active in Disease Refractory to Standard Therapies?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Shikha Jain
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Shikha Jain
137 views
July 16, 2020
Comments 0
Login to view comments.
Click here to Login
GI